Clinical trial: seven-day vonoprazan- versus 14-day proton pump inhibitor-based triple therapy for first-line Helicobacter pylori eradication

Ang, D; Koo, SH; Chan, YH; Tan, TY; Soon, GH; Tan, CK; Lin, KW; Krishnasamy-Balasubramanian, JK; Wong, YJ; Kumar, R; Rajesh, R; Tan, YY; Ong, PLJ; Tan, YLJ; Li, JW; Kwek, ABE; Ang, TL

Ang, D (通讯作者),Changi Gen Hosp, Dept Gastroenterol, 2 Simei St 3, Singapore 529889, Singapore.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022; 56 (3): 436

Abstract

Background/Aim One-week triple therapy with vonoprazan is endorsed by Japanese guidelines as an alternative to proton pump inhibitor (PPI)-based tripl......

Full Text Link